2024-04-09 06:32 | UU:ZOM | | News Release200 | Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 |
2024-04-01 17:14 | UU:ZOM | | SEDAR Annual Report803 | SEDAR Annual Report |
2024-04-01 17:00 | UU:ZOM | | SEDAR MD & A815 | SEDAR MD & A |
2024-04-01 16:53 | UU:ZOM | | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-04-01 16:07 | UU:ZOM | | News Release200 | Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity |
2024-03-30 10:19 | UU:ZOM | | News Release200 | Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET |
2024-03-20 06:32 | UU:ZOM | | News Release200 | Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET |
2024-03-14 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform |
2024-03-13 16:46 | UU:ZOM | | News Release200 | Zomedica Provides NYSE American Listing Update |
2024-03-12 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences |
2024-03-07 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs |
2024-03-05 06:31 | UU:ZOM | | News Release200 | Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024 |
2024-02-08 06:32 | UU:ZOM | | News Release200 | Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences |
2024-02-06 16:33 | UU:ZOM | | News Release200 | Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) |
2024-02-06 06:31 | UU:ZOM | | News Release200 | Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET |
2024-01-31 06:31 | UU:ZOM | | News Release200 | Open Letter to Zomedica Shareholders from your Chief Executive Officer |
2024-01-30 06:31 | UU:ZOM | | News Release200 | Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference |
2024-01-25 16:38 | UU:ZOM | | News Release200 | Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split |
2024-01-17 16:02 | UU:ZOM | | News Release200 | Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split") |
2024-01-10 06:31 | UU:ZOM | | News Release200 | Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Sharehol |
2024-01-04 06:32 | UU:ZOM | | News Release200 | Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel ¢ € œX-Trode ¢ € Handpiece |
2023-12-18 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease |
2023-12-06 06:32 | UU:ZOM | | News Release200 | Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners |
2023-11-28 06:31 | UU:ZOM | | News Release200 | Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference |
2023-11-20 06:31 | UU:ZOM | | News Release200 | Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference |
2023-11-13 18:06 | UU:ZOM | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-13 18:01 | UU:ZOM | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-13 16:22 | UU:ZOM | | News Release200 | Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies |
2023-11-02 06:31 | UU:ZOM | | News Release200 | Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET |
2023-10-11 06:31 | UU:ZOM | | News Release200 | Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference |
2023-10-05 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development |
2023-09-27 06:31 | UU:ZOM | | News Release200 | Zomedica, Inc. to Present at the LD Micro Main Event XVI |
2023-09-14 06:31 | UU:ZOM | | News Release200 | Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing ¢ € ™s Disease in Horses |
2023-09-13 16:32 | UU:ZOM | | News Release200 | Zomedica Provides Corporate Update |
2023-09-05 16:32 | UU:ZOM | | News Release200 | Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio |
2023-08-31 18:20 | UU:ZOM | | News Release200 | Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference |
2023-08-31 06:38 | UU:ZOM | | News Release200 | Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference |
2023-08-10 16:26 | UU:ZOM | | News Release200 | Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity |
2023-08-08 06:31 | UU:ZOM | | News Release200 | Zomedica to Present at Sidoti Virtual Investor Conference August 16-17 |
2023-08-04 06:30 | UU:ZOM | | News Release200 | Zomedica to Host Second Quarter Financial Results Call on August 10 |
2023-08-02 12:54 | UU:ZOM | | News Release200 | RedChip Launches 'Small Stocks, Big Money' Podcast |
2023-06-09 07:31 | UU:ZOM | | News Release200 | Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services |
2023-05-12 16:16 | UU:ZOM | | News Release200 | Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference |
2023-05-11 16:43 | UU:ZOM | | SEDAR Interim Financial Statements812 | SEDAR MD & A |
2023-05-11 16:25 | UU:ZOM | | News Release200 | Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity |
2023-05-08 06:31 | UU:ZOM | | News Release200 | Zomedica Exercises Option to Acquire Structured Monitoring Products |
2023-05-02 06:31 | UU:ZOM | | News Release200 | Zomedica to Host First Quarter Financial Results Call on May 11 |